Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose ephedrine to reduce propofol-induced hemodynamic inhibition in elderly patients
ChiCTR2300071606Phase 4Recruiting
- Sponsor
- Shidong Hospital
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ephedrine in None (2 arms), sponsored by Shidong Hospital. Primary endpoints: Blood pressure and Heart rate. Started May 2023; status: recruiting.
02
Drugs
ephedrine
Beyond the preview
Go deeper on ChiCTR2300071606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071606.